Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00341588 · ClinicalTrials.gov registry record

A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
2,772
Enrollment target

NCT00341588: Completed study, sponsored by National Cancer Institute (NCI).

NCT00341588 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 2,772 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00341588 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
2,772 participants
Enrollment target

Study Summary

The incidence of testicular germ cell tumors (TGCT) has increased during the twentieth century and is of particular concern as it primarily affects young men. It is the most common cancer among U.S. males ages 25-34. The only well-described risk factors are cryptorchism (undescended testis), family history of TGCT, and personal history of TGCT. To better understand the environmental and genetic determinants of TGCT risk, a case-control study will be conducted among members of the U.S. armed forces. The study will include men who have donated a blood sample to the Department of Defense Serum Repository (DoDSR) between 1989 and 2000. All DoDSR donors who have developed GCT will be matched to DoDSR donors who have not developed TGCT. Approximately 1,080 men with TGCT, 1,080 controls, and 2,160 mothers will be included in the study. The DoDSR serum sample will be tested for organochlorines levels, gonadotropin levels, and viral antibody titres. Each participant will donate a saliva specimen that will be used in an examination of genetic susceptibility. Each participant will also complete a questionnaire concerning a variety of possible risk factors such as physical activity, medical history, medication history, and other risk factors. The mothers of all participants will be invited to participate by completing a questionnaire concerning perinatal exposures and events and by donating a saliva sample. The three main objectives of this study are to: * determine whether environmental endocrine modulators (i.e., chlorinated pesticides and polychlorinated biphenyls) are related to risk of GCT and, if so, whether their effects are augmented by other risk factors. * determine whether genetic susceptibility to GCT exists and to characterize the environmental risk factors related to that susceptibility. * determine whether there are distinct causes of GCT by relating the tissue structures of the tumors to the risk factors.

Trial Details

FieldValue
Enrollment Target 2,772 participants
Start Date 2002-01-18
Est. Completion 2020-08-18

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT00341588

The ClinicalTrials.gov registry entry for NCT00341588 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,772 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00341588 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00341588 about?

NCT00341588 is a clinical study titled "A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen". The incidence of testicular germ cell tumors (TGCT) has increased during the twentieth century and is of particular concern as it primarily affects young men. It is the most common cancer among U.S. males ages 25-34. The only well-described risk factors are cryptorchism (undescended testis), family ...

What is the current status of trial NCT00341588?

This trial is currently completed. The enrollment target is 2,772 participants. The study started on 2002-01-18. Estimated completion is 2020-08-18.

Who is sponsoring clinical trial NCT00341588?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.